SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Clinical trials for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear
Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood treatment could give sickle cell patients more time between transfusions
Disease control Not yet recruitingThis study is testing whether blood processed with a special device to keep it low in oxygen works better than regular blood for transfusions in people with sickle cell disease. The goal is to see if this new method helps patients go longer between transfusions and reduces painfu…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope to shield kidneys in sickle cell disease
Disease control Not yet recruitingThis study is testing if a medication called empagliflozin can slow or prevent kidney damage in adults with sickle cell anemia who show early signs of kidney problems. The drug is already approved to protect kidneys in other diseases. Researchers will enroll 20 participants to se…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC